臺灣地區代謝症候群相關疾病改善之經濟效益

Evaluating the Benefitsof Ameliorating Metabolic-Syndrome-Related Diseases in Taiwan

盧介祥(Chieh-Hsiang Lu)；李杰憲(Chieh-Hsien Lee)；盧永祥(Yung-Hsiang Lu)；鍾憲瑞(Hsien-Jui Chung)；莊向薰(Hsiang-Hsun Chuang)

代謝症候群相關疾病 ； 旅行成本法 ； 消費者剩餘 ； 經濟效益 ； Metabolic-syndrome-related diseases ； Travel cost method ； Consumer surplus ； Economic benefits

臺灣經濟預測與政策

45卷1期（2014 / 10 / 01）

77 - 111

繁體中文

本文應用旅行成本法的概念及迴歸模型估計臺閩地區代謝症候群相關疾病罹病者的醫療照護需求函數，並藉由觀察罹病者醫療照護需求及消費者剩餘的變化，探討改善罹病者的健康指標時所能產生的經濟效益。實證結果顯示，若能分別改善臺閩地區代謝症候群相關疾病罹病者的血壓值、膽固醇值及身體質量指數狀況至臨界值的水準，亦即消除高血壓、高膽固醇及過重之風險因子，則可減少個人醫療成本約為11.34億元、2.69億元及4.97億元；可減少總醫療成本約為33.41億元、7.94億元及14.64億元；亦可獲得健康指標改善之經濟效益約為124.54億元、29.83億元及54.89億元。

This paper uses the travel cost method and regression model to evaluate the benefits of ameliorating metabolic-syndrome-related diseases in Taiwan. Data from the ＂Ditmanson Medical Foundation Cha-Yi Christian Hospital＂ and National Health Insurance (NHI) are used for the empirical analysis. The results show that if we can ameliorate risk factors such as hypertension, cholesterol and overweight among metabolic-syndrome-related diseases sufferers so that the risk levels are no higher than level found in the general population, the benefits of ameliorating disease are that the cost of medical service can be reduced NT$ 3.341,$0.794 and $1.464 billion, then add economic benefits NT$12.454, $2.983 and $5.489 billion respectively in Taiwan.

1. 吳珮瑛、廖珮吟(2008)。臺灣主要國家公園之效益評估─納入時間成本之需求體系旅行成本法。農業經濟叢刊，13(2)，1-48。
   連結：
2. 竺凱、鄭蕙燕(2005)。臺灣東部賞鯨旅遊之登船港口遊憩效益評估。農業經濟半年刊，77，45-67。
   連結：
3. 陳凱俐、林雲雀(2005)。不同旅遊需求設定下之遊憩效益之比較─以宜蘭縣為例。農業與經濟，34，91-120。
   連結：
4. 傅祖壇、劉錦添、簡錦漢、賴文龍(2001)。健康風認知與香菸消費行為─臺灣的實證研究。經濟論文，29(1)，91-118。
   連結：
5. 黃錦煌、蕭伯勳、葉純菊(2006)。臺灣咖啡節遊憩效益評估之研究。戶外遊憩研究，19(3)，1-21。
   連結：
6. 鄭蕙燕、張偉祐、林政德(2000)。四草野生動物保護區遊客之遊憩效益與時間成本：截斷式波爾生模型之應用。農業經濟半年刊，67，161-179。
   連結：
7. 中央研究院 (2009), 「臺灣營養健康狀況變遷調查」, http://nahsit.nhri.org.tw/public fro-ntpage?page=3。
8. WHO (2001), The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), Geneva: World Health Organization..
9. Alberini, A.,Alberto, L.(2005).Notadi Lavoro Series 112Notadi Lavoro Series 112,Fondazione Eni Enrico Mattei.
10. Alberti, K. G.,Ziment, P.,Shaw, J.(2005).The Metabolic Syndrome-A New Worldwide Definition.Lancet,366,1059-1062.
11. Anderson, K. M.,Odell, P. M.,Wilson, P. W. F.,Kannel, W. B.(1991).Cardiovascular Disease Risk Profiles.American Heart Journal,121,293-298.
12. Antoni, R. F.(2000).Mass Tourism and the Demand for Protected Natural Areas: A Travel Cost Approach.Journal of Environmental Economics and Management,39,97-116.
13. Becker, G.(1965).A Theory of the Allocation of Time.Economic Journal,75,493-517.
14. Bockstael, N.,Strand, I.,Hanemann, W.(1987).Time and the Recreational Demand Model.American Journal of Agricultural Economics,69(2),293-302.
15. Cauly, S. D.(1987).The Time Price of Medical Care.Review of Economics and Statistics,69(1),59-66.
16. Cesario, F. J.(1974).More on the Generalized Trip Distribution Model.Journal of Regional Science,41(3),389-397.
17. Cesario, F. J.(1976).Value of Time in Recreation Benefit Studies.Land Economics,52(1),32-41.
18. Cesario, F. J.,Knetsch, J. L.(1976).A Recreation Site Demand and Benefit Estimation Model.Regional Studies,10,97-104.
19. Clarke, P. M.(2002).Testing the Convergent Validity of the Contingent Valuation and Travel Cost Methods in Valuing the Benefits of Health Care.Health Economics,11(2),117-127.
20. Clawson, M.(1959).Methods of Measuring the Demand for and Value of Outdoor Recreation.Washington, DC:Resources for the Future.
21. Dardanoni, V.,Wagstaff, A.(1990).Uncertainty and the Demand for Medical Care.Journal of Health Economics,9(1),22-38.
22. Deyak, T. A.,Smith, V. K.(1976).The Economic Value of Statute Reform: The Case of Liberalized Abortion.Journal of Political Economy,84(1),83-99.
23. Ford, E. S.,Giles, W. H.(2003).A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions.Diabetes Care,26,575-581.
24. Gaziano, T. A.(2008).Economic Burden and the Cost-Effectiveness of Treatment of Cardiovascular Diseases in Africa.Heart,94(2),140-144.
25. Getzen, T. E.(2002).Health Care Is an Individual Necessity and a National Luxury: Applying Multilevel Decision Model to the Analysis of Health Care Expenditures.Journal of Health Economics,19(2),259-270.
26. Groot, W.,Henriette, M. B.,Erik, P.(2004).Money for Health: The Equivalent Variation of Cardiovascular Diseases.Health Economics,13(9),859-872.
27. Grossman, M.(1972).On the Concept of Health Capital and the Demand for Health.Journal of Political Economy,80,223-255.
28. Grundy, S. M.,Cleeman, J. I.,Daniels, S. R.(2005).Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/ National Heart, Lung and Blood Institute Scientific Statement.Circulation,112,2735-2752.
29. Jochmann, M.,Gonzalez, R. L.(2004).Estimating the Demand for Health Care with Panel Data: A Semiparametric Bayesian Approach.Health Economics,13(10),1003-1014.
30. Kannel, W. B.,Castelli, W. P.,Gordon, T.,Mcnammara, P. M.(1984).Optimal Resources for Primary Prevention of Atherosclerotic Disease Resource.Circulation,70(1),157-205.
31. Kenkel, D. S.(1991).Health Behavior, Health Knowledge, and Schooling.Journal of Political Economy,99,287-305.
32. Khan, H.(2006).Willingness to Pay for Margalla Hills National Park: Evidence from the Travel Cost Method.Lahore Journal of Economics,11(2),43-70.
33. Liu, J. T.,Hsieh, C. R.(1995).Risk Perception and Smoking Behavior: Empirical Evidence from Taiwan.Journal of Risk and Uncertainty,11,139-157.
34. Manning, W. G.,Newhouse, J. P.,Duan, N.,Keeler, E. B.,Leibowitz, A.(1987).Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment.American Economic Review,77(3),251-277.
35. McConnell, K. E.(1975).Some Problems in Estimating the Demand for Outdoor Recreation.American Journal of Agricultural Economics,57(2),330-334.
36. McConnell, K. E.,Strand, I.(1981).Measuring the Cost of Time in Recreation Demand Analysis.American Journal of Agricultural Economics,63(1),153-156.
37. Meigs, J. B.(2002).Epidemiology of the Metabolic Syndrome.America Journal of Managed Care,8(11),283-296.
38. Newhouse, P. J.,Manning, G. M.,Morris, N. C.(1982).Some Interim Result from a Controlled Trial of Cost-Sharing in Health Insurance.New England Journal of Medicine,305(25),1501-1507.
39. Park, Y. W.,Zhu, S.,Palaniappan, L.,Heshka, S.,Carnethon, M. R.,Heymsfield, S. B.(2003).The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the U.S. Population from the Third National Health and Nutrition Examination Survey, 1988-1994.Archives of Internal Medicine,163(4),427-436.
40. Peter, W. F.,D'Agostino, R. B.,Levy, D.,Belanger, A. M.,Silbershatz, H.,Kannel, W. B.(1998).Prediction of Coronary Heart Disease Using Risk Factor Categories.Circulation,97,1837-1847.
41. Rice, D. P.,Hodgson, T. A.,Sinsheimer, P.,Browner, W.,Kopstein, A. N.(1986).The Economic Cost of the Health Effects of Smoking.The Milbank Quarterly,64(4),489-547.
42. Sacks, F. M.(2004).Metabolic Syndrome: Epidemiology and Consequences.Journal of Clinical Psychiatry,65(18),3-12.
43. Sindelar, J. L.(1982).Differential Use of Medical Care by Sex.Journal of Political Economy,90(5),1003-1019.
44. Suhrcke, M.,Urban, D. M.(2006).CESifo Working Papers, No. 1845CESifo Working Papers, No. 1845,未出版
45. Taylor, T. N.,Davis, P. H.,Torner, J. C.,Holmes, J.,Meyer, J. W.,Jacobson, M. F.(1996).Lifetime Costs of Stroke in the United States.Stroke,27(9),1459-1466.
46. Trogdon, J. G.,Finkelstein, E. A.,Nwaise, I. A.,Tangka, F. K.,Orenstein, D.(2007).The Economic Burden of Chronic Cardiovascular Disease for Major Insurers.Health Promotion Practice,8(3),234-242.
47. Waters, W. G.(1996).Values of Travel Time Savings in Road Transport Project Evaluation.World Transport Research: Proceedings of 7th World Conference on Transport Research,New York:
48. Wood, S.,Trice, A.(1958).Measurement of Recreation Benefits.Land Economics,34(3),195-207.
49. Wu, S. T.,Hsu, F. S.(1989).A Estimation of Recreational Benefit from Water Quality Improvement, the Case of River Tamsuei.Sino-Us Bi-National Conference on Environmental Protection and Social Development,Taipei:
50. 吳珮瑛、曾筱芬、傅祖壇(2009)。心臟血管疾病門診醫療需求及其預防效益之評估─納入異質性病患與就醫相關時間成本。應用經濟叢刊，85，155-194。
51. 李龍騰、張玉坤、黃國晉、潘文涵、陳慶餘(2006)。臺灣地區老年人代謝症候群之盛行率調查。臺灣老年醫學雜誌，1(1)，9-18。
52. 林璟鈺(1999)。碩士論文(碩士論文)。國防醫學院公共衛生學研究所。
53. 許振榮(2001)。碩士論文(碩士論文)。國立臺灣大學公共衛生學研究所。
54. 陳凱俐、溫育芳(1995)。遊憩區經濟效益評估法之應用─以國立宜蘭農工專科學校實驗林場為例。農業經濟叢刊，1(1)，87-116。
55. 傅祖壇、李杰憲(2006)。改善代謝症候群相關疾病之效益衡量─群體歸因風險模式之應用。經濟研究，42(2)，151-182。
56. 黃一展(1995)。碩士論文(碩士論文)。國立臺灣大學公共衛生學研究所。
57. 黃宗煌(1989)。臺灣地區國家公園之遊憩效益的評估。臺灣銀行季刊，41(3)，283-304。
58. 潘文涵(1999)。中央研究院研究計劃報告中央研究院研究計劃報告,未出版
59. 潘文涵(2002)。中央研究院主題研究計畫中央研究院主題研究計畫,未出版
60. 蕭代基(1988)。台灣電力公司委託研究報告台灣電力公司委託研究報告,台灣電力公司。
61. 蕭代基、鄭蕙燕、吳珮瑛、錢玉蘭、溫麗琪(2002)。環境保護之成本效益分析：理論、方法與應用。臺北:俊傑書局股份有限公司。

1. 陳富莉,莊瑋芷(2019)。醫院保健志工代謝症候群培訓課程成效之研究：應用Natural Helper概念。台灣公共衛生雜誌，38(2)，167-177。